DOCSLIB.ORG

August 26, 2021 August 27, 2021 Cusip Symbol Sedol ISIN

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

a. Any security not noted in the list of specials is considered GC. For GC Securities the Mid is LIBOR Flat. b. Citi calculates the pre-trade mid-mark of equity basket swaps and equity index swaps as the half between the interest rate applicable to a short swap on such index or basket and the interest rate applicable to a long swap on such index or basket, expressed as a number of basis points above or below LIBOR. For example, if the applicable interest rate for a long swap on a certain index or basket is LIBOR + 20 bps and the applicable interest rate for a short swap on the same index or basket is LIBOR - 20 bps, the pre-trade mid-mark is LIBOR flat. Calculated as September 30, 2021 at 12:00 Noon NY time, and valid until October 01, 2021 at 12:00 Noon NY time Symbol Cusip Sedol ISIN SecurityDesc UnderLying Ccy Ref Bench Mark Mid ( in bps ) GALXF 039596911 AU000000GXY2 GALAXY RESOURCES LTD AUD 1M BBSW - 2.25 BLMMF 08029K915 6102267 AU000000BKL7 BLACKMORES LTD AUD 1M BBSW - 0.50 BOALF 099509929 6218670 AU000000BLD2 BORAL LTD AUD 1M BBSW - 0.25 CTXAF 130544992 BM91201 AU0000088338 AMPOL LTD AUD 1M BBSW - 0.63 DEXSF 25617L915 DEXUS AUD 1M BBSW - 2.25 34006A910 ORDINARY FULLY PAID AUD 1M BBSW - 2.25 GALXF 38412B925 AU000000GXY2 GALAXY RESOURCES LTD AUD 1M BBSW - 2.25 WEBJF 42764D919 6015815 AU000000WEB7 WEBJET LTD AUD 1M BBSW - 0.25 44016F908 CREDIT CORP GROUP LTD AUD 1M BBSW - 2.25 LGTHF 51799A949 BX17Q13 AU000000CIM7 CIMIC GROUP LTD AUD 1M BBSW - 0.75 MLYSF 58056G972 BF7P002 AU0000013070 MARLEY SPOON AG-CDI GDR AUD 1M BBSW - 4.25 PALAF 71300L929 6668468 AU000000PDN8 PALADIN ENERGY LTD AUD 1M BBSW - 2.75 723711107 PIONEER INTERNATIONAL LTD AUD 1M BBSW - 2.25 CODQL 85256S936 BGV71W0 AU0000026122 CORONADO GLOBAL RESOURCE-CDI 144A GDR AUD 1M BBSW - 2.00 GSCCF 890797905 BGYBHZ4 AU0000028946 IONEER LTD AUD 1M BBSW - 1.25 CTMLF 891608929 B3R1D52 AU000000CTD3 CORPORATE TRAVEL MANAGEMENT AUD 1M BBSW - 0.25 89161B988 VIVA ENERGY GROUP LTD 144A AUD 1M BBSW - 2.25 891798944 B3YPKQ7 AU000000DDR5 DICKER DATA LTD AUD 1M BBSW - 0.88 ORRAF 896445913 ORORA LTD AUD 1M BBSW - 2.25 TPBTF 896Y32915 BJDXBQ1 AU0000050585 BETMAKERS TECHNOLOGY GROUP L AUD 1M BBSW - 3.63 897311965 BYPHBX3 AU000000JLG8 JOHNS LYNG GROUP LTD AUD 1M BBSW - 0.50 ASMMF 897740981 BMTTJZ9 AU0000094153 AUSTRALIAN STRATEGIC MATERIA AUD 1M BBSW - 3.63 94030Z927 6524474 AU000000JIN0 JUMBO INTERACTIVE LTD AUD 1M BBSW - 0.25 00R77M902 BN2R805 BRAMBPACNOR6 AMBIPAR PARTICIPACOES E EMPR BRL 1M LIBOR - 1.50 00R95Z927 BJ1JZ58 BRAPERACNOR9 ALPER CONSULTORIA E CORRETOR BRL 1M LIBOR - 2.80 032493918 BQRS730 BRBBSDCTF000 BB ETF S&P DIVIDENDOS BRASIL FUNDO DE INDICE BRL 1M LIBOR - 1.40 037833902 B4Q8YZ8 BRAAPLBDR004 APPLE INC - BDR GDR BRL 1M LIBOR - 0.75 05961A905 B24C6X0 BROSXBACNOR8 OSX BRASIL SA BRL 1M LIBOR - 1.90 06499G943 B01SCT5 BRBRAPACNOR5 BRADESPAR SA BRL 1M LIBOR - 1.15 06699C924 B08BYR9 BRBOBRACNPR3 BOMBRIL SA PFD BRL 1M LIBOR - 2.75 07399K919 B23F8S9 BRBRSRACNPB4 BANCO DO ESTADO DO RIO GRANDE DO SUL SA PFD BRL 1M LIBOR - 0.35 08098Y9B9 B1VK146 BRPINEACNPR8 BANCO PINE SA PFD BRL 1M LIBOR - 1.95 08213V925 BG0R518 BRBERKBDR002 BERKSHIRE HATHAWAY INC - BDR GDR BRL 1M LIBOR - 1.40 08277X916 BYZDRZ5 BRATOMACNOR1 ATOM PARTICIPACOES SA BRL 1M LIBOR - 2.85 0R0AQ19A8 BD97PR4 BRAZULACNPR4 AZUL SA PFD BRL 1M LIBOR - 1.30 117996918 B0FNPN1 BRINEPACNPR8 INEPAR SA INDUSTRIA E CONSTRUCOES PFD BRL 1M LIBOR - 4.10 149995953 B7N39N0 BRCLSCACNPR3 CENTRAIS ELETRICAS SANTA CATARINA PFD BRL 1M LIBOR - 1.40 151993920 B1YBRK4 BRCMIGACNOR6 CIA ENERGETICA DE MINAS GER BRL 1M LIBOR - 2.15 161610902 BD8ZFB3 BRBIDIACNPR0 BANCO INTER SA 144A PFD BRL 1M LIBOR - 1.40 16309V915 B28XFX2 BRBBRKACNOR4 BRASIL BROKERS PARTICIPACOES BRL 1M LIBOR - 2.25 186996922 B1YCJ34 BRCOCEACNPA3 CIA ENERGETICA DO CEARA PFD BRL 1M LIBOR - 0.90 186997938 2039110 BRCGASACNPA3 CIA DE GAS DE SAO PAULO SA PFD BRL 1M LIBOR - 1.25 20441B944 2200154 BRCPLEACNPB9 CIA PARANAENSE DE ENERGIA PFD BRL 1M LIBOR - 0.90 ELPVF 216992917 2192831 BRCPLEACNOR8 CIA PARANAENSE DE ENERGIA BRL 1M LIBOR - 2.95 228994919 2211747 BRGUARACNOR4 GUARARAPES CONFECCOES SA BRL 1M LIBOR - 0.65 23403A938 B07C6Z5 BRFESAACNPR5 CIA FERRO LIGAS DA BAHIA - FERBASA PFD BRL 1M LIBOR - 1.85 302761911 B4JX546 BREXXOBDR006 EXXON MOBIL - BDR GDR BRL 1M LIBOR - 5.90 373737915 2645443 BRGGBRACNOR1 GERDAU S.A. BRL 1M LIBOR - 0.70 38045R917 B01NTS8 BRGOLLACNPR4 GOL LINHAS AEREAS INTELIGENTES SA PFD BRL 1M LIBOR - 0.55 39154A935 BK8XXW3 BRBIDICDAXX3 BANCO INTER SA UNITS BRL 1M LIBOR - 0.65 39154A950 BKDV8R2 BRBIDIACNOR3 BANCO INTER SA - ORD BRL 1M LIBOR - 2.55 43799J913 B03L0B0 BRGRNDACNOR3 GRENDENE SA BRL 1M LIBOR - 0.40 45599C915 2470515 BRITSAACNOR0 ITAUSA SA BRL 1M LIBOR - 1.15 498348929 2813347 BRKLBNACNPR9 KLABIN SA PFD BRL 1M LIBOR - 2.15 522010909 BJP5P29 BRHBSAACNOR0 HIDROVIAS DO BRASIL SA BRL 1M LIBOR - 2.30 52365A917 B1L86W3 BRLPSBACNOR0 LPS BRASIL CONS DE IMOVEIS BRL 1M LIBOR - 4.55 53114Z971 BRJ9CW2 BRSPXICTF003 IT NOW S&P500 TRN FUNDO DE INDICE BRL 1M LIBOR - 0.65 531575918 BWNH4X2 BRMEALACNOR9 INTERNATIONAL MEAL COMPANY A BRL 1M LIBOR - 0.90 534992250 B1Y4WH5 BRLOGNACNOR3 LOG-IN LOGISTICA INTERMODAL BRL 1M LIBOR - 0.35 568994909 2835578 BRSANBACNPR5 BANCO SANTANDER BRASIL SA PFD BRL 1M LIBOR - 2.15 568994974 B667N41 BRRNEWCDAM15 RENOVA ENERGIA SA UNITS BRL 1M LIBOR - 4.90 57399G913 2599131 BRPOMOACNPR7 MARCOPOLO SA PFD BRL 1M LIBOR - 1.70 588999912 2648840 BRGOAUACNOR1 METALURGICA GERDAU SA BRL 1M LIBOR - 1.50 LUPTF 640281911 B14TFV5 BRLUPAACNOR8 LUPATECH SA BRL 1M LIBOR - 2.15 68291U918 B18XCG7 BRMMXMACNOR2 MMX MINERACAO E METALICOS SA BRL 1M LIBOR - 2.40 688191915 B23FDJ5 BRTPISACNOR8 TPI - TRIUNFO PARTICIPACOES BRL 1M LIBOR - 1.20 69399H957 BF2LP88 BRPPLAUNT007 PPLA PARTICIPATIONS LTD UNITS BRL 1M LIBOR - 1.90 70454P918 2070454 BRBMINACNPR1 BANCO MERCANTIL DE INVESTIMENTOS SA PFD BRL 1M LIBOR - 1.40 712999929 2965141 BRSLEDACNPR7 SARAIVA SA LIVREIROS EDITORES PFD BRL 1M LIBOR - 3.35 71450P985 BL955T6 BRIVVBCTF001 ISHARES S&P 500 FIC FI INVESTIMENTO NO EXTERIOR BRL 1M LIBOR - 0.90 741998918 2672322 BRPNVLACNOR9 DIMED SA DISTRIBUIDORA DE ME BRL 1M LIBOR - 0.25 75699H928 2523367 BRLAMEACNOR9 LOJAS AMERICANAS SA BRL 1M LIBOR - 1.85 768999914 B0WPDR0 BRRSIDACNOR8 ROSSI RESIDENCIAL SA BRL 1M LIBOR - 0.90 786611913 B020DL9 BRPIBBCTF005 IT NOW PIBB IBRX-50 FUNDO DE INDICE BRL 1M LIBOR - 1.40 790998926 2727697 BRRCSLACNPR1 RECRUSUL SA PFD BRL 1M LIBOR - 1.45 804629913 BFMXX80 BRANIMACNOR6 ANIMA HOLDING SA BRL 1M LIBOR - 1.10 SLCJF 834993644 B1Y4WK8 BRSLCEACNOR2 SLC AGRICOLA SA BRL 1M LIBOR - 0.30 83614F969 BJN6MH8 BRSMACCTF001 IT NOW SMALL CAP FUNDO DE INDICE BRL 1M LIBOR - 0.95 836995977 B3K8189 BRBOVACTF003 ISHARES IBOVESPA BRL 1M LIBOR - 0.65 836995993 B3K8178 BRSMALCTF002 ISHARES BM&FBOVESPA SMALL CAP BRL 1M LIBOR - 2.25 8624359A4 2084411 BRBAUHACNPR3 EXCELSIOR ALIMENTOS SA PFD BRL 1M LIBOR - 1.40 862515939 B846PL5 BRXBOVCTF005 CAIXA ETF IBOVESPA FUNDO DE INDICE BRL 1M LIBOR - 1.40 87406A971 BKLH720 BRDDNBBDR008 DOWDUPONT INC-BDR GDR BRL 1M LIBOR - 6.40 880589916 B7XL4M8 BROIBRACNOR1 OI SA BRL 1M LIBOR - 1.65 882265978 2080129 BRBRSRACNOR3 BANCO ESTADO RIO GRANDE SUL BRL 1M LIBOR - 0.40 882266935 2080196 BRBEESACNOR9 BANESTES SA-BANCO ESTADO ESP BRL 1M LIBOR - 2.40 882266968 2849416 BRBIOMACNOR2 BIOMM SA BRL 1M LIBOR - 2.30 882267958 B0765M7 BRRANIACNOR5 IRANI SA BRL 1M LIBOR - 0.50 882268915 2762085 BRSAPRACNPR6 CIA DE SANEAMENTO DO PARANA PFD BRL 1M LIBOR - 3.30 882271935 2189855 BRCYREACNOR7 CYRELA BRAZIL REALTY SA EMP BRL 1M LIBOR - 0.35 882273915 B01GYT3 BRETERACNOR3 ETERNIT SA BRL 1M LIBOR - 0.90 882273972 2380379 BRIGBRACNOR7 IGB ELETRONICA SA BRL 1M LIBOR - 0.90 882273998 B010TS9 BRCGRAACNOR2 GRAZZIOTIN SA BRL 1M LIBOR - 0.90 882274947 B07C730 BRROMIACNOR8 INDUSTRIAS ROMI SA BRL 1M LIBOR - 1.20 882274996 2490245 BRKEPLACNOR1 KEPLER WEBER SA BRL 1M LIBOR - 3.90 882275910 2740359 BRKLBNACNOR2 KLABIN SA BRL 1M LIBOR - 2.15 882275969 B0HZY49 BRLEVEACNOR2 MAHLE-METAL LEVE SA BRL 1M LIBOR - 2.70 882275993 2564667 BRPOMOACNOR0 MARCOPOLO SA BRL 1M LIBOR - 2.70 882276983 B020074 BRMNPRACNOR5 MINUPAR PARTICIPACOES SA BRL 1M LIBOR - 4.40 882279912 B1CHT86 BRSCARACNOR7 SAO CARLOS EMPREENDIMENTOS BRL 1M LIBOR - 0.90 882280969 2906786 BRTUPYACNOR1 TUPY SA BRL 1M LIBOR - 1.70 882281926 B1XFXM1 BRVULCACNOR2 VULCABRAS AZALEIA SA BRL 1M LIBOR - 0.40 882678972 B010DG5 BRFRASACNOR0 FRAS-LE SA BRL 1M LIBOR - 1.35 882681943 2658861 BRPLASACNOR2 PLASCAR PARTICIPACOES SA BRL 1M LIBOR - 2.40 882700909 BF8GMG4 BRNEOEACNOR3 NEOENERGIA SA BRL 1M LIBOR - 0.60 88270G912 2479619 BRGFSAACNOR3 GAFISA SA BRL 1M LIBOR - 1.45 882717945 2835545 BRSTBPACNOR3 SANTOS BRASIL PARTICIPACOES BRL 1M LIBOR - 1.10 88271D918 BMXWTH6 BRAERIACNOR4 AERIS INDUSTRIA E COMERCIO D BRL 1M LIBOR - 1.15 88271G986 BNG2FH2 BRCPLECDAM13 CIA PARANAENSE DE ENERGIA UNITS BRL 1M LIBOR - 1.05 882725906 BD448C6 BRMOVIACNOR0 MOVIDA PARTICIPACOES SA BRL 1M LIBOR - 0.30 88272A913 BF0WB74 BRSAPRCDAM13 CIA DE SANEAMENTO DO PARANA UNITS BRL 1M LIBOR - 0.35 8827649A3 B08ZWK0 BRAZEVACNPR7 AZEVEDO E TRAVASSOS SA PFD BRL 1M LIBOR - 4.90 885688937 BG10ZY9 BRJPSAACNOR6 JEREISSATI PARTICIPACOES SA BRL 1M LIBOR - 1.65 TEBPF 88599B925 2879888 BRTELBACNPR9 TELECOMUNICACOES BRASILEIRAS SA PFD BRL 1M LIBOR - 2.40 889875936 B0W1X34 BRLIGTACNOR2 LIGHT SA BRL 1M LIBOR - 0.45 889941902 B13NPP2 BRVLIDACNOR5 VALID SOLUCOES SA BRL 1M LIBOR - 0.55 889944989 B140CQ2 BRCARDACNOR9 CSU CARDSYSTEM SA BRL 1M LIBOR - 7.25 BRCPF 889944997 B1428Z9 BRAGROACNOR7 BRASILAGRO-CIA BRASILEIRA DE BRL 1M LIBOR - 2.20 88999B9Z8 BYNQSR5 BRCRPGACNPA3 CRISTAL PIGMENTOS DO BRASIL SA PFD BRL 1M LIBOR - 3.40 890129976 B1FRH89 BRMDIAACNOR7 M DIAS BRANCO SA BRL 1M LIBOR - 1.05 890133952 B1G92Q7 BRPFRMACNOR1 PROFARMA DISTRIBUIDORA BRL 1M LIBOR - 1.95 890153919 B1H6R62 BRODPVACNOR4 ODONTOPREV S.A.
Recommended publications
  • Cameron Tait P Post

    Cameron Tait P Post

    TRANSITION Meeting Britain’s energy BY needs together CONSENT Cameron Tait p post ABOUT THE FABIAN SOCIETY The Fabian Society is Britain’s oldest political think tank. Since 1884 the society has played a central role in developing political ideas and public policy on the left. It aims to promote greater equality of power and opportunity; the value of collective public action; a vibrant, tolerant and accountable democracy; citizenship, liberty and human rights; sustainable development; and multilateral international co-operation. Through a wide range of publications and events the society influences political and public thinking, but also provides a space for broad and open-minded debate, drawing on an unrivalled external network and its own expert research and analysis. Its programme offers a unique breadth, encompassing national conferences and expert seminars; periodicals, books, reports and digital communications; and commissioned and in-house research and comment. The Society is alone among think tanks in being a democratically-constituted membership organisation, with almost 7,000 members. Over time our membership has included many of the key thinkers on the British left and every Labour prime minister. Today we count over 200 parliamentarians in our number. The voluntary society includes 70 local societies, the Fabian Women’s Network and the Young Fabians, which is itself the leading organisation on the left for young people to debate and influence political ideas. The society was one of the original founders of the Labour party and is constitutionally affiliated to the party. We are however editorially, organisationally and financially independent and work with a wide range of partners from all political persuasions and none.
  • Scientific Committee on Vaccine Preventable Diseases and Scientific Committee on Emerging and Zoonotic Diseases

    Scientific Committee on Vaccine Preventable Diseases and Scientific Committee on Emerging and Zoonotic Diseases

    Scientific Committee on Emerging and Zoonotic Disease and Scientific Committee on Vaccine Preventable Diseases Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of Jan 7, 2021) Introduction The ongoing COVID-19 pandemic causes a significant disease burden worldwide. In Hong Kong, cases and outbreaks continue to be reported. To reduce the impacts of COVID-19 on health and society, vaccines against COVID-19 is considered an important public health tool for containing the pandemic in the medium and long term. On 7 January 2021, the Scientific Committee on Emerging and Zoonotic Diseases (SCEZD), the Scientific Committee on Vaccine Preventable Diseases (SCVPD), and the Expert Advisory Panel to Chief Executive (EAP) reviewed the latest scientific evidence on the epidemiology and clinical features of COVID-19, published data on the COVID- 19 vaccines be procured by the Hong Kong SAR Government, local data as well as overseas recommendations/practices, and provides recommendations on the population groups and circumstances for the use of COVID-19 vaccines in Hong Kong. COVID-19 Vaccines 2. At the meeting held on 13 August 2020, the joint SCEZD and SCVPD together with the EAP reviewed the then scientific development of COVID 19 vaccines and prioritization of target groups for COVID 19 vaccines in Hong Kong. The meeting recommended that vaccine procurement would be aimed at the whole Hong Kong population in the long run. In anticipation of a limited supply at the early stage when vaccines are available, a phased approach has to be taken with certain priority groups of the local population identified to be vaccinated first, in order to reduce morbidity and mortality and maintain essential services.
  • Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA

    Retirement Strategy Fund 2060 Description Plan 3S DCP & JRA

    Retirement Strategy Fund 2060 June 30, 2020 Note: Numbers may not always add up due to rounding. % Invested For Each Plan Description Plan 3s DCP & JRA ACTIVIA PROPERTIES INC REIT 0.0137% 0.0137% AEON REIT INVESTMENT CORP REIT 0.0195% 0.0195% ALEXANDER + BALDWIN INC REIT 0.0118% 0.0118% ALEXANDRIA REAL ESTATE EQUIT REIT USD.01 0.0585% 0.0585% ALLIANCEBERNSTEIN GOVT STIF SSC FUND 64BA AGIS 587 0.0329% 0.0329% ALLIED PROPERTIES REAL ESTAT REIT 0.0219% 0.0219% AMERICAN CAMPUS COMMUNITIES REIT USD.01 0.0277% 0.0277% AMERICAN HOMES 4 RENT A REIT USD.01 0.0396% 0.0396% AMERICOLD REALTY TRUST REIT USD.01 0.0427% 0.0427% ARMADA HOFFLER PROPERTIES IN REIT USD.01 0.0124% 0.0124% AROUNDTOWN SA COMMON STOCK EUR.01 0.0248% 0.0248% ASSURA PLC REIT GBP.1 0.0319% 0.0319% AUSTRALIAN DOLLAR 0.0061% 0.0061% AZRIELI GROUP LTD COMMON STOCK ILS.1 0.0101% 0.0101% BLUEROCK RESIDENTIAL GROWTH REIT USD.01 0.0102% 0.0102% BOSTON PROPERTIES INC REIT USD.01 0.0580% 0.0580% BRAZILIAN REAL 0.0000% 0.0000% BRIXMOR PROPERTY GROUP INC REIT USD.01 0.0418% 0.0418% CA IMMOBILIEN ANLAGEN AG COMMON STOCK 0.0191% 0.0191% CAMDEN PROPERTY TRUST REIT USD.01 0.0394% 0.0394% CANADIAN DOLLAR 0.0005% 0.0005% CAPITALAND COMMERCIAL TRUST REIT 0.0228% 0.0228% CIFI HOLDINGS GROUP CO LTD COMMON STOCK HKD.1 0.0105% 0.0105% CITY DEVELOPMENTS LTD COMMON STOCK 0.0129% 0.0129% CK ASSET HOLDINGS LTD COMMON STOCK HKD1.0 0.0378% 0.0378% COMFORIA RESIDENTIAL REIT IN REIT 0.0328% 0.0328% COUSINS PROPERTIES INC REIT USD1.0 0.0403% 0.0403% CUBESMART REIT USD.01 0.0359% 0.0359% DAIWA OFFICE INVESTMENT
  • Notice of 2020 Annual Meeting of Shareholders

    Notice of 2020 Annual Meeting of Shareholders

    10 Ha-Menofim St., 5th Floor Herzliya, Israel 4672561 NOTICE OF 2020 ANNUAL MEETING OF SHAREHOLDERS June 25, 2020 NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders (the “Annual Meeting”) of Cyren Ltd., a company formed under the laws of the State of Israel, will be held on July 30, 2020 at 11:00 a.m. Eastern Time, at the offices of our subsidiary, Cyren Inc., located at 1430 Spring Hill Road, Suite 330, McLean, VA 22102, for the following purposes: 1. to elect nine directors, as described in the accompanying proxy statement, to serve until the next annual meeting of shareholders or until their successors are elected; 2. to approve the compensation to our Chairman of the Board; 3. to approve the equity-based compensation to our Chief Executive Officer; 4. to approve, as required by Nasdaq Listing Rule 5635(d), the issuance of more than 19.99% of our outstanding ordinary shares in connection with our 5.75% Convertible Debentures due 2024; 5. to ratify and approve the re-appointment of Kost, Forer, Gabbay & Kasierer (a member firm of Ernst & Young Global) as our independent registered public accountants for the year ending December 31, 2020 and for the year commencing January 1, 2021 and until the next annual meeting of shareholders and to authorize our Board of Directors and Audit Committee to determine its fees; 6. to approve, on an advisory basis, the compensation of our named executive officers; 7. to review and discuss our consolidated financial statements for the fiscal year ended December 31, 2019; and 8.
  • TCL 科技集团股份有限公司 TCL Technology Group Corporation

    TCL 科技集团股份有限公司 TCL Technology Group Corporation

    TCL Technology Group Corporation Annual Report 2019 TCL 科技集团股份有限公司 TCL Technology Group Corporation ANNUAL REPORT 2019 31 March 2020 1 TCL Technology Group Corporation Annual Report 2019 Table of Contents Part I Important Notes, Table of Contents and Definitions .................................................. 8 Part II Corporate Information and Key Financial Information ........................................... 11 Part III Business Summary .........................................................................................................17 Part IV Directors’ Report .............................................................................................................22 Part V Significant Events ............................................................................................................51 Part VI Share Changes and Shareholder Information .........................................................84 Part VII Directors, Supervisors, Senior Management and Staff .......................................93 Part VIII Corporate Governance ..............................................................................................113 Part IX Corporate Bonds .......................................................................................................... 129 Part X Financial Report............................................................................................................. 138 2 TCL Technology Group Corporation Annual Report 2019 Achieve Global Leadership by Innovation and Efficiency Chairman’s
  • Kandi Technologies Group, Inc

    Kandi Technologies Group, Inc

    Kandi Technologies Group, Inc. Investor Presentation March 2016 NASDAQ GS: KNDI www.KandiTechnologiesGroup.com 2 SAFE HARBOR STATEMENT Except for historical information contained herein, the statements made in the presentation of Kandi Technologies Group, Inc. (the “Company”) are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product demand, market competition, and government policies. These and other risks are described in the Company’s filings with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. These forward-looking statements speak as of the date hereof. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. 2 Kandi Introduction 4 Kandi at a Glance o Founded in 2002 o NASDAQ GS: KNDI (listed since March 2008) o Stock Price: $8.56* o Market Cap: $402.5M (47,019,638* outstanding shares) o Three-month Average Daily Volume: 575,228 Shares* o Headquarters: Jinhua, Zhejiang Province, China o Three full-scale production facilities in Shanghai, Jinhua, and Changxing o Facility in Jiangsu Rugao, ready for product sales in 2Q16 o Facility in Haikou, under construction 4 * As of March 15, 2016 5 Business Overview Leading pure EV products 50/50 Joint Venture with provider in China.
  • Market Cap Close ADV 1598 67Th Pctl 745,214,477.91 $ 23.96

    Market Cap Close ADV 1598 67Th Pctl 745,214,477.91 $ 23.96

    Market Cap Close ADV 1598 67th Pctl $ 745,214,477.91 $ 23.96 225,966.94 801 33rd Pctl $ 199,581,478.89 $ 10.09 53,054.83 2399 Ticker_ Listing_ Effective_ Revised Symbol Security_Name Exchange Date Mkt Cap Close ADV Stratum Stratum AAC AAC Holdings, Inc. N 20160906 M M M M-M-M M-M-M AAMC Altisource Asset Management Corp A 20160906 L M L L-M-L L-M-L AAN Aarons Inc N 20160906 H H H H-H-H H-H-H AAV Advantage Oil & Gas Ltd N 20160906 H L M H-L-M H-M-M AB Alliance Bernstein Holding L P N 20160906 H M M H-M-M H-M-M ABG Asbury Automotive Group Inc N 20160906 H H H H-H-H H-H-H ABM ABM Industries Inc. N 20160906 H H H H-H-H H-H-H AC Associated Capital Group, Inc. N 20160906 H H L H-H-L H-H-L ACCO ACCO Brand Corp. N 20160906 H L H H-L-H H-L-H ACU Acme United A 20160906 L M L L-M-L L-M-L ACY AeroCentury Corp A 20160906 L L L L-L-L L-L-L ADK Adcare Health System A 20160906 L L L L-L-L L-L-L ADPT Adeptus Health Inc. N 20160906 M H H M-H-H M-H-H AE Adams Res Energy Inc A 20160906 L H L L-H-L L-H-L AEL American Equity Inv Life Hldg Co N 20160906 H M H H-M-H H-M-H AF Astoria Financial Corporation N 20160906 H M H H-M-H H-M-H AGM Fed Agricul Mtg Clc Non Voting N 20160906 M H M M-H-M M-H-M AGM A Fed Agricultural Mtg Cla Voting N 20160906 L H L L-H-L L-H-L AGRO Adecoagro S A N 20160906 H L H H-L-H H-L-H AGX Argan Inc N 20160906 M H M M-H-M M-H-M AHC A H Belo Corp N 20160906 L L L L-L-L L-L-L AHL ASPEN Insurance Holding Limited N 20160906 H H H H-H-H H-H-H AHS AMN Healthcare Services Inc.
  • Advancing Cell Therapeutic Products for Clinical Use

    Advancing Cell Therapeutic Products for Clinical Use

    Advancing cell therapeutic products for clinical use 1 Proprietary data of Pluristem Therapeutics Inc. Forward Looking Statement This presentation concerning Pluristem Therapeutics may include forward- looking statements which represent Pluristem Therapeutics' expectations or beliefs regarding future events. I caution that such statements involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Consequently, all such forward-looking statements are qualified by the cautionary language and risk factors set forth in Pluristem Therapeutics' periodic and other reports filed with the SEC. There can be no assurance that the actual results, events or developments referenced in such forward-looking statements will occur or be realized. Pluristem Therapeutics assumes no obligation to update these forward- looking statements to reflect actual results, changes in assumptions or changes in factors affecting such forward-looking statements. www.pluristem.com 2 Proprietary data of Pluristem Therapeutics Inc. Corporate Overview • Cell therapy company (NasdaqCM: PSTI, TASE: PSTI) • Using off-the-shelf, placenta-derived cells to achieve both local and systemic therapeutic effects – no tissue matching needed • First-in-class 3D cell culturing technology allowing for efficient, controlled production of multiple cell products in commercial quantities – “the process is the product” • Active with regulators in the U.S., EU, S. Korea, Australia & Israel • Demonstrated safety and efficacy in 3 clinical studies (two Phase I and one Phase I/II study) 3 Proprietary data of Pluristem Therapeutics Inc. Financial Overview • Market Cap: ~ $200 million • Cash and marketable securities: $41 million (March, 2015) • No debt • Net burn: ~ $23 million • 165 employees (16 PhD, 4 MD) • IP Ownership: over 40 granted patents and ~150 pending applications 4 Proprietary data of Pluristem Therapeutics Inc.
  • Sun Life Global Investments (Canada) Inc

    Sun Life Global Investments (Canada) Inc

    February 22, 2019 Sun Life Global Investments (Canada) Inc. SIMPLIFIED PROSPECTUS Offering Series A, Series AT5, Series T5, Series T8, Series D, Series F, Series F5, Series F8, Series FT5, Series I and Series O securities as indicated. Sun Life Granite Conservative Portfolio (Series A, T5, F, F5, I, O securities) Sun Life Granite Moderate Portfolio (Series A, T5, F, F5, I, O securities) Sun Life Granite Balanced Portfolio (Series A, T5, D, F, F5, I, O securities) Sun Life Granite Balanced Growth Portfolio (Series A, T5, T8, F, F5, F8, I, O securities) Sun Life Granite Growth Portfolio (Series A, T5, T8, F, F5, F8, I, O securities) Sun Life Granite Income Portfolio (Series A, T5, F, F5, I, O securities) Sun Life Granite Enhanced Income Portfolio (Series A, F, I, O securities) Sun Life Sentry Value Fund (Series A, F, I, O securities) Sun Life Infrastructure Fund† (Series A, F, I, O securities) Sun Life Schroder Global Mid Cap Fund (Series A, T5, T8, F, F5, F8, I, O securities) Sun Life Dynamic American Fund (Series A, T5, T8, F, F5, F8, I, O securities) Sun Life Templeton Global Bond Fund (Series A, F, I, O securities) Sun Life Dynamic Equity Income Fund (Series A, F, I, O securities) Sun Life Dynamic Strategic Yield Fund (Series A, F, I, O securities) Sun Life NWQ Flexible Income Fund (Series A, F, I, O securities) Sun Life BlackRock Canadian Equity Fund (Series A, T5, T8, F, F5, F8, I and O securities) Sun Life BlackRock Canadian Balanced Fund (Series A, T5, F, F5, I and O securities) Sun Life MFS Canadian Bond Fund (Series A, D, F, I and O securities) Sun Life MFS Canadian Equity Growth Fund (Series A, D, F, I and O securities) Sun Life MFS Dividend Income Fund (Series A, D, F, I and O securities) Sun Life MFS U.S.
  • Petition of the Procter & Gamble Company for Approval of Proposed Divestiture

    Petition of the Procter & Gamble Company for Approval of Proposed Divestiture

    PUBLIC RECORD VERSION UNITED STATES OF AMERICA BEFÖRE FEDERAL TRADE COMMISSION COMMISSIONERS: Deborah Platt Majoras, Chairman Pamela Jones Harbour Jon Leibowitz Wiliam E. Kovacic J. Thomas Rosch ) In the Matter of ) ) THEa corporation;PROCTER & GAMBLE COMPANY, ) ) ) Docket No. C-4151 and ) File No. 051-0115 ) THE GILLETTE COMPANY, ) a corporation., ) ) ) PETITION OF THE PROCTER & GAMBLE COMPANY FOR APPROVAL OF PROPOSED DIVESTITURE Pursuant to Section 2.41(f) of the Federal Trade Commission ("Commission" or "FTC") Rules of Practice and Procedure, 16 CF.R. § 2.41(f) (2005), and Paragraph II.A. of the final Decision and Order approved by the Commission in the above-captioned matter, The Procter & Gamble Company ("P&G") hereby fies this Petition for Approval of Proposed Divestitue ("Petition") requesting the Commission's approval of the divestitue of the APDO business, including Right Guard, Soft & Dri, Dry Idea, Natrel Plus, and Balance ("the APDO Assets") of The Gilette Company ("Gilette"), to The Dial Corporation ("Dial"), a subsidiar of Henkel KGaA ("Henkel"). .~ PUBLIC RECORD VERSION I. INTRODUCTION On September 23,2005, P&G and the Commission entered into an Agreement Containing Consent Orders, including an initial Decision and Order and an Order to Maintain Assets. On October 1,2005, pursuant to an Agreement and Plan of Merger between P&G and Gilette dated Januar 27, 2005, P&G completed its acquisition of Gilette. After a period of public comment, on December 15, 2005, the Commission issued its final Decision and Order , ("Order") (with minor changes) and Order to Maintain Assets (without changes) (collectively, the "Consent Agreement"). At the same time it reissued its Complaint (also without changes).
  • Digest of United Kingdom Energy Statistics 2017

    Digest of United Kingdom Energy Statistics 2017

    DIGEST OF UNITED KINGDOM ENERGY STATISTICS 2017 July 2017 This document is available in large print, audio and braille on request. Please email [email protected] with the version you require. Digest of United Kingdom Energy Statistics Enquiries about statistics in this publication should be made to the contact named at the end of the relevant chapter. Brief extracts from this publication may be reproduced provided that the source is fully acknowledged. General enquiries about the publication, and proposals for reproduction of larger extracts, should be addressed to BEIS, at the address given in paragraph XXVIII of the Introduction. The Department for Business, Energy and Industrial Strategy (BEIS) reserves the right to revise or discontinue the text or any table contained in this Digest without prior notice This is a National Statistics publication The United Kingdom Statistics Authority has designated these statistics as National Statistics, in accordance with the Statistics and Registration Service Act 2007 and signifying compliance with the UK Statistics Authority: Code of Practice for Official Statistics. Designation can be broadly interpreted to mean that the statistics: ñ meet identified user needs ONCEñ are well explained and STATISTICSreadily accessible HAVE ñ are produced according to sound methods, and BEENñ are managed impartially DESIGNATEDand objectively in the public interest AS Once statistics have been designated as National Statistics it is a statutory NATIONALrequirement that the Code of Practice S TATISTICSshall continue to be observed IT IS © A Crown copyright 2017 STATUTORY You may re-use this information (not including logos) free of charge in any format or medium, under the terms of the Open Government Licence.
  • NASDAQ Stock Market

    NASDAQ Stock Market

    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85